Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("MORTON, Donald L")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 80

  • Page / 4
Export

Selection :

  • and

The role of lymphatic mapping and sentinel node biopsy in the management of atypical and anomalous melanocytic lesionsCOCHRAN, Alistair J; BINDER, Scott; MORTON, Donald L et al.Journal of cutaneous pathology. 2010, Vol 37, pp 54-59, issn 0303-6987, 6 p., SUP1Article

Surgery and Sentinel Lymph Node BiopsyFARIES, Mark B; MORTON, Donald L.Seminars in oncology. 2007, Vol 34, Num 6, pp 498-508, issn 0093-7754, 11 p.Article

Earlier diagnosis of second primary melanoma confirms the benefits of patient education and routine postoperative follow-upDIFRONZO, L. Andrew; WANEK, Leslie A; MORTON, Donald L et al.Cancer. 2001, Vol 91, Num 8, pp 1520-1524, issn 0008-543XConference Paper

Microphthalmia transcription factor as a molecular marker for circulating tumor cell detection in blood of melanoma patientsKOYANAGI, Kazuo; O'DAY, Steven J; HOON, Dave S. B et al.Clinical cancer research. 2006, Vol 12, Num 4, pp 1137-1143, issn 1078-0432, 7 p.Article

Endogenous immune response to gangliosides in patients with confined prostate cancerRAVINDRANATH, Mepur H; MUTHUGOUNDER, Sakunthala; PRESSER, Naftali et al.International journal of cancer. 2005, Vol 116, Num 3, pp 368-377, issn 0020-7136, 10 p.Article

Melanoma recurrence patterns after negative sentinel lymphadenectomy. DiscussionZOGAKIS, Theresa G; ESSNER, Richard; GREIF, Jon M et al.Archives of surgery (Chicago, IL. 1960). 2005, Vol 140, Num 9, pp 865-872, issn 0004-0010, 8 p.Conference Paper

Sentinel node biopsy for early-stage melanoma : Accuracy and morbidity in MSLT-I, an international multicenter trial. DiscussionMORTON, Donald L; COCHRAN, Alistair J; KARAKOUSIS, Constantine P et al.MORTON, Donald L; MORTON, Donald L; Annals of surgery. 2005, Vol 242, Num 3, pp 302-313, issn 0003-4932, 12 p.Conference Paper

Contemporary surgical treatment of advanced-stage melanoma. DiscussionESSNER, Richard; LEE, Jonathan H; WANEK, Leslie A et al.Archives of surgery (Chicago, IL. 1960). 2004, Vol 139, Num 9, pp 961-967, issn 0004-0010, 7 p.Conference Paper

Androgen blockade enhances response to melanoma vaccineHSUEH, Eddy C; GUPTA, Rishab K; LEFOR, Alan et al.The Journal of surgical research. 2003, Vol 110, Num 2, pp 393-398, issn 0022-4804, 6 p.Article

Role of sentinel lymphadenectomy in thin invasive cutaneous melanomasBLEICHER, Richard J; ESSNER, Richard; FOSHAG, Leland J et al.Journal of clinical oncology. 2003, Vol 21, Num 7, pp 1326-1331, issn 0732-183X, 6 p.Article

Serum total ganglioside level correlates with clinical course in melanoma patients after immunotherapy with therapeutic cancer vaccineRAVINDRANATH, Mepur H; HSUEH, Eddy C; VERMA, Meena et al.Journal of immunotherapy (1997). 2003, Vol 26, Num 3, pp 277-285, issn 1524-9557, 9 p.Article

Enhanced humoral immune response correlates with improved disease-free and overall survival in American Joint Committee on Cancer stage II melanoma patients receiving adjuvant polyvalent vaccineDIFRONZO, L. Andrew; GUPTA, Rishab K; ESSNER, Richard et al.Journal of clinical oncology. 2002, Vol 20, Num 15, pp 3242-3248, issn 0732-183XArticle

Prolonged survival after complete resection of disseminated melanoma and active immunotherapy with a therapeutic cancer vaccineHSUEH, Eddy C; ESSNER, Richard; FOSHAG, Leland J et al.Journal of clinical oncology. 2002, Vol 20, Num 23, pp 4549-4554, issn 0732-183X, 6 p.Article

Assessment of Prognostic Circulating Tumor Cells in a Phase III Trial of Adjuvant Immunotherapy After Complete Resection of Stage IV MelanomaHOSHIMOTO, Sojun; FARIES, Mark B; LEE, Jeffrey E et al.Annals of surgery. 2012, Vol 255, Num 2, pp 357-362, issn 0003-4932, 6 p.Article

Combined Intralesional Bacille Calmette-Guérin (BCG) and Topical Imiquimod for In-transit MelanomaKIDNER, Travis B; MORTON, Donald L; LEE, Delphine J et al.Journal of immunotherapy (1997). 2012, Vol 35, Num 9, pp 716-720, issn 1524-9557, 5 p.Article

Prognostic Significance of Mitotic Rate in Localized Primary Cutaneous Melanoma: An Analysis of Patients in the Multi-Institutional American Joint Committee on Cancer Melanoma Staging DatabaseTHOMPSON, John F; SOONG, Seng-Jaw; LEONG, Stanley P et al.Journal of clinical oncology. 2011, Vol 29, Num 16, pp 2199-2205, issn 0732-183X, 7 p.Article

Management of Popliteal Sentinel Nodes in MelanomaSTEEN, Shawn T; KARGOZARAN, Hamed; MORAN, Christopher J et al.Journal of the American College of Surgeons. 2011, Vol 213, Num 1, pp 180-186, issn 1072-7515, 7 p.Conference Paper

Aberrant Fatty Acid-Binding Protein-7 Gene Expression in Cutaneous Malignant MelanomaGOTO, Yasufumi; KOYANAGI, Kazuo; HOON, Dave S. B et al.Journal of investigative dermatology. 2010, Vol 130, Num 1, pp 221-229, issn 0022-202X, 9 p.Article

Monocyte-derived IL-10 Expression Predicts Prognosis of Stage IV Melanoma PatientsTORISU-ITAKURA, Hitoe; LEE, Jonathan H; HUYNH, Young et al.Journal of immunotherapy (1997). 2007, Vol 30, Num 8, pp 831-838, issn 1524-9557, 8 p.Article

Vaccine therapy for melanoma : Current status and future directionsTERANDO, Alicia M; FARIES, Mark B; MORTON, Donald L et al.Vaccine. Supplement. 2007, Vol 25, Num 2, issn 1359-5938, B4-B16Article

Sentinel lymphadenectomy does not increase the incidence of in-transit metastases in primary melanomaKANG, John C; WANEK, Leslie A; ESSNER, Richard et al.Journal of clinical oncology. 2005, Vol 23, Num 21, pp 4764-4770, issn 0732-183X, 7 p.Conference Paper

Phase I pilot clinical trial of human IgM monoclonal antibody to ganglioside GM3 in patients with metastatic melanomaIRIE, Reiko F; OLLILA, David W; O'DAY, Steven et al.Cancer immunology and immunotherapy. 2004, Vol 53, Num 2, pp 110-117, issn 0340-7004, 8 p.Article

Molecular tumor markers in the blood: Early prediction of disease outcome in melanoma Patients treated with a melanoma vaccineWASCHER, Robert A; MORTON, Donald L; KUO, Christine et al.Journal of clinical oncology. 2003, Vol 21, Num 13, pp 2558-2563, issn 0732-183X, 6 p.Article

Antigen-based immunotherapy of melanoma: Canvaxin therapeutic polyvalent cancer vaccineHSUEH, Eddy C; MORTON, Donald L.Seminars in cancer biology. 2003, Vol 13, Num 6, pp 401-407, issn 1044-579X, 7 p.Article

Human High Molecular Weight-Melanoma-Associated Antigen : Utility for Detection of Metastatic Melanoma in Sentinel Lymph NodesGOTO, Yasufumi; FERRONE, Soldano; ARIGAMI, Takaaki et al.Clinical cancer research. 2008, Vol 14, Num 11, pp 3401-3407, issn 1078-0432, 7 p.Article

  • Page / 4